A phase 3 clinical trial of treatment for idiopathic pulmonary fibrosis, sponsored by Weill Cornell Medicine, could pave the way for cheaper studies that are easier to conduct.
A team led by researchers at Weill Cornell Medicine and their colleagues has developed a machine learning technique for identifying genetic mutations that trigger the disease.
During the COP26 climate change conference, 45 Cornell undergraduate and graduate students plugged in from Ithaca to hear international negotiations first-hand and environmental history.
Excess sugar in the blood, the central feature of diabetes, can react with immune proteins to cause myriad changes in the immune system, including inflammatory changes that promote atherosclerosis, according to a new study.
The College of Human Ecology on May 1 held its fourth annual HumEcathon, a hackathon-style design challenge bringing together 27 undergraduates to work in multidisciplinary teams on diversity, equity and inclusion initiatives on campus.
Normal blood levels of vitamin D don’t affect one’s susceptibility to getting COVID-19 or the severity of infections, according to new research led by Bonnie Patchen, a doctoral student in the field of nutrition.
Cornell’s nearly 50-year-old Empathy, Assistance and Referral Service (EARS) will begin offering a new model of support this fall, including peer mentoring, training and outreach.
Dr. Geraldine McGinty, an esteemed clinical operations strategist, administrator and radiologist, has been appointed senior associate dean for clinical affairs at Weill Cornell Medicine, effective Sept. 1.